The rising interest in GLP-1 agonists for diabetes has sparked a discussion about delivery methods : patches versus pills . Typically, GLP-1 therapies were exclusively available in tablet form, but the emergence of transdermal delivery presents a alternative way. Skin applications might be advantageous for individuals with challenges taking oral… Read More